Phase I/II chemosensitization trial of burixafor in combination with fludarabine and cytarabine in adults with relapsed or refractory acute myeloid leukemia
Latest Information Update: 02 Sep 2015
At a glance
- Drugs Burixafor (Primary) ; Cytarabine; Fludarabine
- Indications Stem cell mobilisation
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Mar 2015 New trial record
- 18 Mar 2015 According to a TaiGen Biotechnology media release, this trial is planned for 2015.